|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.56 INR | +4.99% |
|
+4.99% | +21.44% |
| Market Cap | 116M 1.21M 1.05M 969K 908K 1.7M 1.73M 11.56M 4.48M 55.91M 4.55M 4.45M 194M | P/E Ratio 2024 |
-128x | P/E Ratio 2025 | -53.4x |
|---|---|---|---|---|---|
| Enterprise Value | 116M 1.21M 1.05M 968K 907K 1.69M 1.73M 11.55M 4.47M 55.84M 4.54M 4.44M 194M | EV / Sales 2024 |
38,257,531x | EV / Sales 2025 | - |
| Free-Float |
48.09% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +4.99% | ||
| 1 week | +4.99% | ||
| Current month | +4.99% | ||
| 1 month | +10.20% | ||
| 3 months | +15.66% | ||
| 6 months | +27.49% | ||
| Current year | +21.44% |
| 1 week | 23.56 | 23.56 | |
| 1 month | 22.44 | 23.56 | |
| Current year | 19.4 | 23.56 | |
| 1 year | 15.98 | 23.56 | |
| 3 years | 3.34 | 23.56 | |
| 5 years | 3.16 | 23.56 | |
| 10 years | 3.16 | 23.56 |
| Manager | Title | Age | Since |
|---|---|---|---|
Rattan Kapoor
CEO | Chief Executive Officer | - | 16/10/2025 |
| Director of Finance/CFO | - | 28/10/2025 | |
B. V. Harish
COO | Chief Operating Officer | - | 28/10/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 22/06/2021 | |
| Director/Board Member | - | 21/04/2022 | |
Rattan Kapoor
BRD | Director/Board Member | - | 16/10/2025 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +4.99% | +4.99% | +47.43% | +333.09% | 1.34M | ||
| +2.42% | +3.58% | +44.15% | +161.75% | 1,013B | ||
| +0.35% | +5.00% | +54.31% | +49.83% | 574B | ||
| +0.81% | +0.78% | +18.38% | +64.60% | 397B | ||
| -0.37% | +4.97% | +21.24% | +15.95% | 324B | ||
| +0.85% | +0.18% | +24.50% | +14.78% | 280B | ||
| +2.10% | +4.92% | +25.30% | +33.80% | 273B | ||
| +5.45% | +2.75% | +21.69% | +63.37% | 182B | ||
| -0.19% | -0.46% | -45.32% | -48.35% | 194B | ||
| +4.26% | -1.91% | +15.93% | +62.74% | 151B | ||
| Average | +2.05% | +2.88% | +22.76% | +75.16% | 338.86B | |
| Weighted average by Cap. | +1.54% | +3.99% | +29.93% | +73.29% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.12 0.01 0.01 0.01 0.01 0.02 0.02 0.11 0.04 0.54 0.04 0.04 1.87 | - |
| Net income | -406K -4.24K -3.68K -3.39K -3.18K -5.94K -6.06K -40.46K -15.66K -196K -15.92K -15.57K -680K | -1.26M -13.16K -11.42K -10.53K -9.86K -18.43K -18.81K -126K -48.62K -607K -49.4K -48.33K -2.11M |
| Net Debt | -9.31M -97.23K -84.38K -77.78K -72.88K -136K -139K -928K -359K -4.49M -365K -357K -15.6M | -137K -1.43K -1.24K -1.14K -1.07K -2K -2.05K -13.65K -5.29K -66.04K -5.37K -5.26K -230K |
Employees
1
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/06/26 | 23.56 ₹ | +4.99% | 3,519 |
- Stock Market
- Stocks
- 531240 Stock
Select your edition
All financial news and data tailored to specific country editions
















